Medibiofarma — Seed (estimated) · €2M

Medibiofarma completed a €2M financing round from its founding team and new partners, with Sodena (Government of Navarre) committing €1M. The money was to advance its R&D programmes, especially MBF-118, a PPARγ modulator due to enter the clinic in the second half of 2019.